Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The True Benefits Of AUTOMATED SOFTWARE TESTING

Testing measures quality. This statement is never truer than in medical device development. Automated testing augments other processes to dramatically improve product reliability, predictability, and productivity. It reduces anomaly, field service, product support, and liability costs. Properly designed, it provides quality metrics for your organization to review and analyze. Given the proper environment, automated testing…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Testing measures quality. This statement is never truer than in medical device development. Automated testing augments other processes to dramatically improve product reliability, predictability, and productivity. It reduces anomaly, field service, product support, and liability costs. Properly designed, it provides quality metrics for your organization to review and analyze. Given the proper environment, automated testing can accelerate development cycles, and provide a tangible return on investment (ROI) for the developer and end user.

Another benefit of automated testing is that it allows for testing that can be difficult or cost prohibitive for people to run. For example, Software Quality Assurance (SQA) automation may reduce costs when regression testing/smoke tests are run after nightly builds to ensure that if a bug has been introduced in the latest commit, that it is found as quickly as possible. Another example is testing different versions of software/hardware configurations as quickly as possible. Automated testing provides benefits throughout the software development lifecycle, decreasing verification test time and increasing reliability with supplemental manual testing.

What You Need to Know About Automated Testing

From a process point of view, automated testing may occur at different phases of the development process: unit testing, integration testing, verification testing, software system testing, and overall system testing. At each point, engineers need to define whether a test should be manual, automated, or a combination of the two. Automated unit testing is beneficial as it can be executed whenever a module is changed. Testing in the other phases of development should be discussed as a cost-benefit analysis. A project that is planned to be updated continually during its lifetime will benefit from automated testing to ensure maintenance releases do not accidently cause adverse side effects.

Automated testing is not without challenges:

  • Includes supporting cell/line qualifications through manufacturing validations such as Operational Qualification (OQ) and Performance Qualification (PQ)
  • It can be expensive and time consuming to develop
  • SQA engineers can be difficult to hire
  • Manual testing can be “good enough” and be considered less costly
  • Projects may not have the budget necessary to support automated testing
  • Project architecture may not allow for automated testing
  • Manual testing is often better at distinguishing minor oddities in graphical user interfaces (GUI)

Despite these challenges, automated testing is improving all the time and can provide continuous, repeatable testing of a product. This results in better quality metrics, which helps plan for future development.

How Automated Testing Can Help Your Project

Four reasons automated testing may be right for your project:

  • Test protocols are written based on requirements, not individual testers
  • Testing can be easily re-executed throughout the development cycle including regression testing or smoke testing
  • Testing can be performed under challenging system level conditions
  • Testing can be designed to exclude destructive testing of mechanical or electronics components

Companies interested in automated testing should start by reviewing the system architecture to see where automated testing can be beneficial and consider tools such as VectorCAST (C or C++ code) and J-Unit (Java Code) that help decrease cost of automated testing. Use an Agile methodology to write the test before the software is written and be sure to include team members with automated testing experience to drive appropriate, efficient processes.

Here at Sunrise Labs, we recommend considering automated testing as part of your test strategy. Automated testing can benefit product development outcomes by allowing testing under continuous use conditions, providing repeatable quality data. This can give valuable insights to developers regarding the end user experience with the device, saving money on maintenance, support, and liability costs.

Learn more about the SERVICES we provide at Sunrise Labs.

Read more at sunriselabs.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512